Voyager Acquisition, a blank check company targeting the healthcare sector, filed on Tuesday with the SEC to raise up to $261 million in an initial public offering.
The Houston, TX-based company plans to raise $261 million by offering 26.1 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At the proposed deal size, Voyager Acquisition would command a market value of $326 million.
The company is led by CEO and Director Adeel Rouf, a former Investment Professional at Cohen and Company Asset Management, and Chairman Warren Hosseinion, who currently serves as President of Nutex Health and previously co-founded Apollo Medical Holdings. It plans to target the healthcare and healthcare-related industries, focusing on businesses with enterprise values between $160 million and $2 billion.
Rouf has held various roles with several other SPACs, including currently serving as COO of Northern Revival Acquisition (NRAC; trading suspended since February 2024), which has a pending merger agreement with Australia-based agtech Braiin. He also previously served as CFO of Founder SPAC, which merged with Rubicon Technologies (BMV: RBT; -97% from $10 offer price) in 2022.
Voyager Acquisition was founded in 2023 and plans to list on the Nasdaq under the symbol VACHU. Cantor Fitzgerald is the sole bookrunner on the deal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.